Results 161 to 170 of about 1,116,406 (351)

Comparison of Lidocaine and Prilocaine for Intravenous Regional Anesthesia [PDF]

open access: bronze, 1988
Angela M. Bader   +3 more
openalex   +1 more source

Preservation of ALYREF Phase Separation Mitigates Doxorubicin‐Induced Cardiomyocyte DNA Damage and Cardiotoxicity

open access: yesAdvanced Science, EarlyView.
Binding of Doxorubicin to ALYREF disrupts its phase‐separated condensate and induces DNA damage and apoptosis in cardiomyocytes Abstract The clinical utility of the anticancer agent doxorubicin (DOX) is limited by its dose‐dependent cardiotoxicity.
Xinlu Gao   +20 more
wiley   +1 more source

The global trend of intravenous anesthesia and tumors: a bibliometric and visualized study. [PDF]

open access: yesPerioper Med (Lond)
Han F   +8 more
europepmc   +1 more source

INTRAVENOUS REGIONAL ANESTHESIA

open access: bronze, 1967
Ronald W. Dunbar, Richard I. Mazze
openalex   +1 more source

Confusion Regarding Experimental Studies of Intravenous Regional Anesthesia [PDF]

open access: bronze, 1986
S. C. Grice   +2 more
openalex   +1 more source

Engineered Substrate‐Free Small Molecules for Enhanced Raman Scattering and Photothermal Conversion Efficiency

open access: yesAdvanced Science, EarlyView.
A molecular engineering strategy is developed to increase the stacking‐induced intermolecular charge transfer‐enhanced Raman scattering (SICTERS) intensity and photothermal conversion efficiency of electron donor‐acceptor‐donor (D–A–D) molecules. This approach enables to design SICTERS‐mediated photo‐theranostic agents for substrate‐free Raman image ...
Sheng Yu   +9 more
wiley   +1 more source

Propofol Total Intravenous Anesthesia for Pediatric Proton Radiotherapy and Its Effect on Patient Outcomes. [PDF]

open access: yesCancers (Basel)
Owusu-Agyemang P   +11 more
europepmc   +1 more source

Intravenous Lidocaine as an adjunct to general anesthesia

open access: bronze, 1960
Otto C. Phillips   +5 more
openalex   +1 more source

Inhibition of AMPKα Pathway by Podocyte GOLM1 Exacerbates Diabetic Nephrology in Mice

open access: yesAdvanced Science, EarlyView.
Podocyte Golgi membrane protein 1 interacts with epidermal growth factor receptor to inhibit peroxisome proliferator activated receptor γ, and then inactivates adenosine monophosphate activated protein kinase α pathway, which facilitates diabetes‐related inflammation, oxidative damage, apoptosis, and renal dysfunction.
Peng Xu   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy